If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Business Operations » Benchmarking and Quality » Quality » Quality Teams
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Non-members: Click here to sign-up for a complimentary tour of
"Pharma R & D Quality Assurance: Staffing and Use of Risk-Based Approach Programs"
This study is aimed at helping pharmaceutical R&D Quality Assurance executives tackle two current challenges: optimizing limited QA staff resources and implementing Risk-Based Approach guidelines for GxP oversight. This study identifies ratios of QA organization size relative to the size of the R&D functional areas they serve. Organizations are also evaluated on their level of Risk-Based Approach and its impact on QA workload and management.
QA leaders can use this 39-slide presentation to gauge their staffing levels as well as FTE distribution across the GCP, GLP and GMP functions. They will also get a look at where pharma companies are today in preparing for risk-based assessment.
Key Metrics and Topic Areas:
Sample Key Findings: